農業バイオテクノロジー市場規模、シェア、動向、2030年までの世界予測

農業バイオテクノロジー市場 – 生物の種類（植物、動物、微生物）、種類別、技術別、用途別 – 2030年までの世界予測

農業バイオテクノロジー市場は、2025年には921億9,000万米ドルに達すると推定され、CAGR 9.4%で成長し、2030年までに1,442億5,000万米ドルに達すると予測されています。

農業バイオテクノロジー市場の成長は、世界的な食糧需要の増加、耕作地の減少、そして持続可能な農業ソリューションへのニーズによって主に推進されています。バイオテクノロジーは、環境への影響を軽減しながら、作物の収量増加、土壌の健全性向上、家畜の生産性向上を実現する高度な手法を提供します。遺伝子組み換え（GM）作物、微生物接種剤、バイオ肥料の利用増加は、資源管理の改善と化学物質への依存度の低減に貢献しています。さらに、気候変動への圧力により、干ばつ耐性や害虫抵抗性を持つ作物品種の導入が加速し、農業のレジリエンス（回復力）が向上しています。各国政府や国際機関は、支援的な規制、研究資金、持続可能性への取り組みを通じて、バイオテクノロジーの革新を奨励しています。さらに、ゲノム編集、分子診断、微生物工学の急速な進歩は、植物、動物、微生物システムにおける農業バイオテクノロジーの活用を拡大しています。これらの要因が相まって、世界中でハイテクで環境に優しく、高収量農業への移行が進んでいます。

この調査レポートでは、農業バイオテクノロジー市場を、生物の種類（植物、動物、微生物）、タイプ（遺伝子組み換え、作物保護、土壌改良、ストレス耐性、トランスジェニック動物、ワクチン、飼料添加物、診断、生物肥料、生物防除剤、微生物酵素および生物刺激剤、微生物ゲノミクスおよび発酵）、技術（遺伝子工学、分子診断、組織培養、CRISPR、発酵、メタゲノミクス、合成生物学、分子マーカー支援選抜）、用途（作物保護、収穫量増加、病害抵抗性、動物の健康管理、土壌健全性改善、持続可能な栄養循環）、エンドユーザー（農家および生産者グループ、アグリビジネス、種子および投入物企業、研究機関、政府機関）、および地域（北米、ヨーロッパ、アジア太平洋、南米、中東、アフリカ）別に分類しています。

本レポートは、農業バイオテクノロジーの成長に影響を与える推進要因、制約要因、課題、機会といった主要な要因に関する詳細な情報を提供しています。主要業界プレーヤーの包括的な分析を通じて、各社の事業、サービス、主要戦略、契約、パートナーシップ、合意、製品発売、合併・買収、そして農業バイオテクノロジー市場における最近の動向に関する洞察を提供しています。また、本レポートでは、農業バイオテクノロジーエコシステムにおける新興スタートアップ企業の競合分析も掲載しています。さらに、技術分析、エコシステムと市場のマッピング、特許および規制の状況など、業界特有のトレンドについても調査しています。

本レポートは、市場リーダー企業と新規参入企業に対し、農業バイオテクノロジーセクター全体とそのサブセグメントの概算収益数値を提供します。また、ステークホルダーが競争環境を理解し、事業のポジショニングを改善し、効果的な市場開拓戦略を策定するための洞察を得るのに役立ちます。さらに、本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供するのに役立ちます。

本レポートでは、以下の点について考察しています。

• 農業バイオテクノロジー市場の成長に影響を与える主要な推進要因（持続可能で高収量なバイオテクノロジー農業への需要の高まり）、制約要因（遺伝子組み換え作物に対する高い規制上のハードルと長期にわたる承認プロセス）、機会（微生物およびバイオベースの農業資材の世界的な導入増加）、課題（遺伝子組み換え技術に対する国民の懐疑心と倫理的懸念）の分析
• 製品開発／イノベーション：ゲノム編集、CRISPR応用、微生物バイオ肥料、生物防除剤といった進行中の研究開発イニシアチブに関する詳細な分析に加え、植物、動物、微生物バイオテクノロジー分野における新製品の発売状況も掲載しています。
• 市場開発：本レポートは、先進地域および新興地域における市場機会の拡大に関する包括的な情報を提供し、バイオテクノロジーを活用した農業への投資増加に焦点を当てています。
• 市場の多様化：新製品のイノベーション、地域における導入パターン、政府資金によるバイオテクノロジーイニシアチブ、主要企業による気候変動耐性作物や動物衛生ソリューションといった新規用途への進出に関する詳細な分析を掲載しています。
• 競合評価: 農業バイオテクノロジーエコシステムにおける、Bayer AG (ドイツ)、Corteva Agriscience (米国)、BASF SE (ドイツ)、Syngenta AG (スイス)、Novonesis (デンマーク)、Ginkgo Bioworks (米国)、Zoetis Inc. (米国)、ADM Animal Nutrition (米国) などの主要企業の市場シェア、企業戦略、製品ポートフォリオ、イノベーションの足跡を詳細に評価します。

Report Overview

The agriculture biotechnology market is estimated at USD 92.19 billion in 2025 and is projected to reach USD 144.25 billion by 2030, at a CAGR of 9.4%.

The growth of the agriculture biotechnology market is mainly driven by increasing global food demand, diminishing arable land, and the need for sustainable farming solutions. Biotechnology provides advanced methods to increase crop yields, improve soil health, and boost livestock productivity while reducing environmental impact. The rising use of genetically modified (GM) crops, microbial inoculants, and biofertilizers supports better resource management and less reliance on chemicals. Moreover, climate change pressures have sped up the adoption of drought-tolerant and pest-resistant crop varieties, ensuring greater resilience in farming. Governments and international groups are encouraging biotech innovations through supportive regulations, research funding, and sustainability efforts. Additionally, quick progress in genome editing, molecular diagnostics, and microbial engineering is broadening the use of agricultural biotechnology in plant, animal, and microbial systems. Collectively, these factors are driving a shift toward high-tech, eco-friendly, and high-yield agriculture worldwide.

“Plant biotechnology is projected to dominate the market during the forecast period.”

The plant biotechnology segment is expected to dominate the global agriculture biotechnology market during the forecast period. This leadership is due to widespread adoption of genetically modified (GM) crops, advancements in seed trait development, and increased use of biofertilizers and biopesticides. Rising global food demand, combined with the need for higher crop yields with limited natural resources, is fueling the adoption of plant biotechnology solutions. Farmers are increasingly opting for GM varieties that offer herbicide tolerance, pest resistance, and improved stress tolerance to achieve better yields and profits. Additionally, innovations in CRISPR and molecular breeding technologies are enhancing precision in crop improvement, enabling faster commercialization of new varieties. Supportive government policies promoting sustainable agriculture, along with public-private R&D investments, are further reinforcing this segment’s position. The growing need for climate-resilient and nutrient-rich crops will continue to make plant biotechnology a key driver of innovation in modern agriculture throughout the forecast period.

“The genetic engineering and genome editing subsegment is projected to dominate the agriculture biotechnology market during the forecast period.”

The genetic engineering and genome editing segment is expected to lead the agriculture biotechnology market during the forecast period due to its transformative effect on crop and livestock improvement. Technologies like CRISPR-Cas9, TALEN, and RNA interference (RNAi) are allowing scientists to create precise, high-yield varieties with better yield, stress tolerance, and nutritional content. An example is Calyxt’s gene-edited soybean, which produces healthier high-oleic oil and was among the first CRISPR-based crops to be commercialized in the US. Likewise, Corteva Agriscience has developed drought-tolerant maize using advanced gene-editing methods, greatly enhancing resilience in water-scarce areas.

In livestock, Genus PLC has developed pigs resistant to Porcine Reproductive and Respiratory Syndrome (PRRS), a breakthrough that enhances animal welfare and cuts economic losses. Governments in Brazil, the US, and Argentina have also relaxed regulations on gene-edited crops, supporting faster commercialization. Supported by strong R&D investments, global partnerships, and evolving biosafety frameworks, genetic engineering and genome editing are set to remain the leading technologies that drive efficiency, sustainability, and innovation in agricultural biotechnology through 2030.

“Asia Pacific is projected to be the fastest-growing market during the forecast period.”

The Asia Pacific region is expected to see the fastest growth in the agriculture biotechnology market during the forecast period, fueled by increasing food demands, expanding agricultural modernization, and government-supported initiatives that promote sustainable farming practices. Countries like China, India, Japan, and the Philippines are increasingly investing in biotechnology R&D to improve crop yields, livestock health, and soil fertility. The rising adoption of genetically modified (GM) crops, microbial biofertilizers, and bio-based pest control products is transforming the region’s agricultural landscape.

India’s approval of GM mustard (Dhara Mustard Hybrid-11) in 2023 and China’s increasing commercialization of gene-edited soybean and maize varieties highlight the region’s progressive regulatory approach. Additionally, strong support from regional organizations and public-private partnerships is driving innovation in genome editing, fermentation technologies, and microbial applications. With rapid population growth, limited arable land, and growing focus on food security, the Asia Pacific region is expected to remain the most dynamic and opportunity-rich area in the agriculture biotechnology market through 2030.

In-depth interviews were conducted with chief executive officers (CEOs), directors, and other executives from various key organizations in the agriculture biotechnology market.

• By Company Type: Tier 1–25%, Tier 2–45%, and Tier 3–30%
• By Designation: CXOs–20%, Managers–50%, Executives–30%
• By Region: North America–25%, Europe–20%, Asia Pacific–30%, South America–15%, and Rest of the World–10%

Prominent companies in the market include Bayer Crop Science, Corteva Agriscience, BASF SE, Syngenta AG, Zoetis Inc., Elanco Animal Health, and Novonesis (Novozymes and Chr. Hansen)

Research Coverage

This research report categorizes the agriculture biotechnology market by organism type (plants, animals, microbes), type (genetic modification, crop protection, soil enhancement, stress tolerance, transgenic animals, vaccines, feed additives, diagnostics, biofertilizers, biocontrol agents, microbial enzymes & biostimulants, microbial genomics & fermentation), technology (genetic engineering, molecular diagnostics, tissue culture, CRISPR, fermentation, metagenomics, synthetic biology, and molecular marker-assisted selection), application (crop protection, yield enhancement, disease resistance, animal health management, soil health improvement, and sustainable nutrient cycling), end user (farmers and producer groups, agribusinesses, seed and input companies, research institutions, and government agencies), and region (North America, Europe, Asia Pacific, South America, the Middle East, and Africa).

The report’s scope includes detailed information about major factors such as drivers, restraints, challenges, and opportunities that influence the growth of agricultural biotechnology. A comprehensive analysis of key industry players offers insights into their businesses, services, key strategies, contracts, partnerships, agreements, product launches, mergers and acquisitions, and recent developments in the agriculture biotechnology market. This report also features a competitive analysis of emerging startups within the agriculture biotechnology ecosystem. Additionally, the study covers industry-specific trends such as technology analysis, ecosystem and market mapping, and patent and regulatory landscapes, among other topics.

Reasons to Buy This Report

The report will provide market leaders and new entrants with approximate revenue figures for the overall agriculture biotechnology sector and its subsegments. It will also help stakeholders understand the competitive landscape and gain insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp the market pulse and offers information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points.

• Analysis of key drivers (growing demand for sustainable and high-yield biotechnology-based agriculture), restraints (high regulatory hurdles and lengthy approval processes for GMOs), opportunities (increasing adoption of microbial and bio-based agricultural inputs globally), and challenges (public skepticism and ethical concerns over genetic modification technologies) influencing the growth of the agriculture biotechnology market
• Product Development/Innovation: Detailed insights into ongoing R&D initiatives in genome editing, CRISPR applications, microbial biofertilizers, and biocontrol agents are included, along with emerging product launches across plant, animal, and microbial biotechnology segments.
• Market Development: The report offers comprehensive information about expanding market opportunities across developed and emerging regions, emphasizing growing investment in biotechnology-enabled agriculture.
• Market Diversification: Includes detailed analysis of new product innovations, regional adoption patterns, government-funded biotechnology initiatives, and expansion of key players into new applications such as climate-resilient crops and animal health solutions.
• Competitive Assessment: In-depth assessment of market share, company strategies, product portfolios, and innovation footprints of leading players such as Bayer AG (Germany), Corteva Agriscience (US), BASF SE (Germany), Syngenta AG (Switzerland), Novonesis (Denmark), Ginkgo Bioworks (US), Zoetis Inc. (US), and ADM Animal Nutrition (US), among others in the agriculture biotechnology ecosystem.

Table of Contents

1          INTRODUCTION  46

1.1        STUDY OBJECTIVES       46

1.2        MARKET DEFINITION        46

1.3        STUDY SCOPE   47

1.3.1      MARKET SEGMENTATION AND REGIONS COVERED 47

1.3.2      INCLUSIONS AND EXCLUSIONS     48

1.3.3      YEARS CONSIDERED       49

1.4        UNITS CONSIDERED        49

1.4.1      CURRENCY CONSIDERED 49

1.5        STAKEHOLDERS 50

2          RESEARCH METHODOLOGY         52

2.1        RESEARCH DATA            52

2.1.1      SECONDARY DATA         53

2.1.1.1    Key data from secondary sources    53

2.1.2      PRIMARY DATA  53

2.1.2.1    Key data from primary sources        54

2.1.2.2    Key primary participants    54

2.1.2.2.1  AGRICULTURE BIOTECHNOLOGY COMPANIES        54

2.1.2.3    Breakdown of primary interviews     55

2.1.2.4    Key industry insights         55

2.2        MARKET SIZE ESTIMATION           56

2.2.1      BOTTOM-UP APPROACH 57

2.2.2      TOP-DOWN APPROACH  58

2.3        DATA TRIANGULATION    61

2.4        FACTOR ANALYSIS         62

2.5        RESEARCH ASSUMPTIONS           63

2.6        RESEARCH LIMITATIONS  64

3          EXECUTIVE SUMMARY     65

4          PREMIUM INSIGHTS         71

4.1        AGRICULTURE BIOTECHNOLOGY MARKET OVERVIEW            71

4.2        AGRICULTURE BIOTECHNOLOGY MARKET: GROWTH RATES OF MAJOR REGIONAL SUBMARKETS         72

4.3        EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET FOR PLANT BIOTECHNOLOGY,

BY TYPE AND COUNTRY  73

4.4        AGRICULTURE BIOTECHNOLOGY MARKET, BY ORGANISM TYPE AND REGION          74

4.5        MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY            75

4.6        ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION            75

4.7        PLANT BIOTECHNOLOGY MARKET, BY APPLICATION            76

5          MARKET OVERVIEW         77

5.1        INTRODUCTION  77

5.2        MARKET DYNAMICS        77

5.2.1      DRIVERS            78

5.2.1.1    Growing Need for Sustainable Food Production          78

5.2.1.2    Government Support and Regulatory Approvals          79

5.2.1.3    Rising Focus on Reducing Chemical Inputs     79

5.2.2      RESTRAINTS      79

5.2.2.1    Public Perception and Ethical Concerns        79

5.2.2.2    Infrastructure and Cold Chain Limitations      80

5.2.3      OPPORTUNITIES 80

5.2.3.1    Expansion in Emerging Economies    80

5.2.3.2    Focus on Carbon-negative and Regenerative Agriculture            81

5.2.3.3    Growth in Microbial and Bio-based Inputs      81

5.2.4      CHALLENGES     82

5.2.4.1    Regulatory Uncertainty and Trade Barriers    82

5.2.4.2    Dominance of Few Multinational Players        82

5.2.4.3    Climate and Disease Variability       82

5.3        IMPACT OF GEN AI ON AGRICULTURE BIOTECHNOLOGY            83

5.3.1      INTRODUCTION  83

5.3.2      USE OF GEN AI IN AGRICULTURE BIOTECHNOLOGY            84

5.3.3      CASE STUDY ANALYSIS   85

5.3.3.1    Using Gen AI to Enhance Crop Disease Diagnostics via

Synthetic Imagery 85

5.3.3.2    PhytoSynth: Generative AI for Crop Disease Data Generation            85

5.3.4      IMPACT ON AGRICULTURE BIOTECHNOLOGY MARKET            86

5.3.5      ADJACENT ECOSYSTEM WORKING ON GEN AI        86

6          INDUSTRY TRENDS         87

6.1        INTRODUCTION  87

6.2        PORTER’S FIVE FORCES ANALYSIS          87

6.2.1      INTENSITY OF COMPETITIVE RIVALRY       88

6.2.2      BARGAINING POWER OF SUPPLIERS         88

6.2.3      BARGAINING POWER OF BUYERS  89

6.2.4      THREAT OF SUBSTITUTES           89

6.2.5      THREAT OF NEW ENTRANTS        89

6.3        MACROECONOMIC INDICATORS   89

6.3.1      GLOBAL POPULATION GROWTH & FOOD DEMAND  89

6.3.2      STABLE GLOBAL GDP GROWTH AND MACRO PROJECTIONS            90

6.4        SUPPLY CHAIN ANALYSIS            91

6.5        VALUE CHAIN ANALYSIS  92

6.6        ECOSYSTEM ANALYSIS   93

6.6.1      DEMAND SIDE     94

6.6.2      SUPPLY SIDE     94

6.7        INDICATIVE PRICING ANALYSIS    94

6.7.1      INDICATIVE PRICING ANALYSIS, BY KEY COMPANY AND ORGANISM         95

6.7.2      INDICATIVE PRICING BY REGION   97

6.8        TRADE ANALYSIS           99

6.8.1      TRADE ANALYSIS OF HS CODE 843280: PREPARED CULTURE MEDIA FOR DEVELOPMENT OR MAINTENANCE OF MICROORGANISMS, INCLUDING VIRUSES AND THE LIKE, OR OF PLANT, HUMAN, OR ANIMAL CELLS   99

6.8.1.1    Export Trends of Agriculture Biotechnology under HS Code

382100 (2020–2024)         99

6.8.1.2    Import Trends of Agriculture Biotechnology under HS Code

382100 (2020–2024)         100

6.9        KEY CONFERENCES & EVENTS     103

6.10       TRENDS IMPACTING CUSTOMERS’ BUSINESSES    104

6.11       INVESTMENT AND FUNDING SCENARIO     105

6.12       CASE STUDY ANALYSIS   106

6.12.1     PIVOT BIO’S GENE-EDITED NITROGEN-FIXING MICROBES (2025)    106

6.12.2     NOVONESIS MICROBIAL SEED INOCULANT (JUMPSTART®) (2024)    106

6.12.3     RECOMBINETICS — GENE-EDITED LIVESTOCK FOR DISEASE RESISTANCE AND WELFARE ENHANCEMENT (2024) 107

6.13       IMPACT OF 2025 US TARIFF – AGRICULTURE BIOTECHNOLOGY MARKET          107

6.13.1     INTRODUCTION  107

6.13.2     KEY TARIFF RATES         108

6.13.3     PRICE IMPACT ANALYSIS 108

6.13.4     IMPACT ON COUNTRY/REGION    110

6.13.4.1  United States      110

6.13.4.2  European Union   110

6.13.4.3  China     110

6.13.5     IMPACT ON END-USE INDUSTRIES            110

7          CUSTOMER LANDSCAPE & BUYER BEHAVIOR        111

7.1        INTRODUCTION  111

7.2        DECISION-MAKING PROCESS       111

7.3        BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA            112

7.3.1      KEY STAKEHOLDERS IN BUYING PROCESS 112

7.3.2      BUYING CRITERIA           113

7.4        ADOPTION BARRIERS & INTERNAL CHALLENGES    114

7.5        UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES            114

7.6        MARKET PROFITABILITY  115

8          STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,

AND AI ADOPTION          116

8.1        INTRODUCTION  116

8.2        KEY EMERGING TECHNOLOGIES   116

8.3        COMPLEMENTARY TECHNOLOGIES           117

8.4        TECHNOLOGY/PRODUCT ROADMAP         118

8.5        PATENT ANALYSIS          118

8.5.1      LIST OF MAJOR PATENTS           120

8.6        FUTURE APPLICATIONS  124

8.7        IMPACT OF AI/GEN AI ON AGRICULTURE BIOTECHNOLOGY MARKET 124

8.7.1      TOP USE CASES AND MARKET POTENTIAL            125

8.7.1.1    AI Use Cases in Agriculture Biotechnology Market      125

8.7.1.1.1  AI-driven Genomic Selection and Trait Discovery        125

8.7.1.1.2  Precision Bio-input Design and Microbial Optimization 125

8.7.1.1.3  Market Potential Impact of AI in Agricultural Biotechnology            125

8.7.1.1.4  Acceleration of R&D and Commercialization Pipelines  125

8.7.1.1.5  Enabling Data-driven Sustainable Agriculture and Global Scalability           126

8.7.2      BEST PRACTICES IN AGRICULTURE BIOTECHNOLOGY PROCESSING     126

8.7.3      CASE STUDIES OF AI IMPLEMENTATION IN AGRICULTURE BIOTECHNOLOGY MARKET          127

8.7.3.1    Using Gen AI to Enhance Crop Disease Diagnostics via Synthetic Imagery  127

8.7.3.2    PhytoSynth: Generative AI for Crop Disease Data Generation            128

8.7.4      INTERCONNECTED & ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS     128

8.7.5      CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN AGRICULTURE BIOTECHNOLOGY MARKET 128

8.8        SUCCESS STORIES AND REAL-WORLD APPLICATIONS            129

9          SUSTAINABILITY AND REGULATORY LANDSCAPE   130

9.1        INTRODUCTION  130

9.2        REGIONAL REGULATIONS AND COMPLIANCE         130

9.2.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS  130

9.2.2      INDUSTRY STANDARDS   133

9.3        SUSTAINABILITY INITIATIVES        134

9.3.1      CARBON IMPACT AND ECO-APPLICATIONS OF AGRICULTURE BIOTECHNOLOGY  134

9.4        SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES        134

9.5        CERTIFICATIONS, LABELING, ECO-STANDARDS      135

10         AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM         137

10.1       INTRODUCTION  138

10.2       PLANTS 139

10.2.1     GROWING GLOBAL FOOD DEMAND, CLIMATE CHANGE RESILIENCE, AND SUSTAINABILITY GOALS ACCELERATING ADOPTION OF PLANT BIOTECHNOLOGY    139

10.3       ANIMALS           140

10.3.1     RISING PROTEIN DEMAND, DISEASE PREVENTION NEEDS, AND SUSTAINABLE LIVESTOCK PRODUCTION DRIVING ANIMAL BIOTECHNOLOGY ADVANCEMENTS           140

10.4       MICROBIALS      141

10.4.1     RISING DEMAND FOR SUSTAINABLE SOIL HEALTH, BIOFERTILIZERS, AND ECO-FRIENDLY PEST CONTROL DRIVES MICROBIAL BIOTECHNOLOGY GROWTH     141

11         AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE            143

11.1       INTRODUCTION  144

11.2       PLANT BIOTECHNOLOGY MARKET, BY TYPE          144

11.2.1     GROWING FOCUS ON ENHANCING CROP YIELD, STRESS RESISTANCE, AND SUSTAINABILITY          144

11.2.2     GENETIC MODIFICATION  149

11.2.2.1  Crop protection (Biopesticides, Herbicide-tolerant Traits)            149

11.2.2.1.1            Rising pest resistance, yield loss, and sustainability goals drive innovation in biotechnology-based crop protection           149

11.2.2.2  Soil enhancement (Biofertilizers, Microbial Solutions)   150

11.2.2.2.1            Declining soil fertility and sustainable farming practices are driving demand for biotechnology-based soil enhancement solutions            150

11.2.2.3  Stress tolerance (Drought/Heat-resistant Crops)       150

11.2.2.3.1            Climate change, erratic weather, and yield instability are driving demand for stress-tolerant biotechnology crops            150

11.2.2.4  Animal biotechnology market, by type           150

11.2.2.4.1            Focus on improving livestock productivity, health, and genetic performance         150

11.2.3     TRANSGENIC ANIMALS    152

11.2.3.1  Animal vaccine development           152

11.2.3.1.1            Increasing livestock diseases and zoonotic threats drive demand for advanced biotechnology-based animal vaccine solutions            152

11.2.3.2  Feed additives & nutrient optimization          153

11.2.3.2.1            Rising demand for efficient, sustainable livestock production drives adoption of biotechnology-based feed additives globally            153

11.2.3.3  Animal health diagnostics   153

11.2.3.3.1            Growing disease incidence and need for early detection drive innovation in biotechnology-based animal diagnostics       153

11.2.3.4  Microbial biotechnology market, by type        153

11.2.3.4.1            Expanding use of microbes in agriculture enhances yield and sustainability 153

11.2.4     MICROBIAL BIOFERTILIZERS        155

11.2.4.1  Biocontrol agents (Fungi, Bacteria)  156

11.2.4.1.1            Stringent pesticide regulations and growing demand for residue-free, sustainable crop protection accelerate biocontrol adoption globally  156

11.2.4.2  Microbial enzymes & biostimulants   157

11.2.4.2.1            Rising demand for eco-friendly, stress-resilient crop enhancement solutions drives microbial enzyme and biostimulant adoption globally  157

11.2.4.3  Microbial genomics & fermentation   158

11.2.4.3.1            Advancements in microbial genomics and precision fermentation enable high-efficiency, scalable bio-based agricultural innovations globally           158

12         AGRICULTURE BIOTECHNOLOGY MARKET, BY APPLICATION            159

12.1       INTRODUCTION  160

12.2       PLANT BIOTECHNOLOGY MARKET, BY APPLICATION            160

12.2.1     CROP PROTECTION        161

12.2.1.1  Increasing pest resistance and need for sustainable pest control drive innovation in biotech crop protection    161

12.2.2     YIELD ENHANCEMENT     162

12.2.2.1  Rising food demand and limited arable land accelerate adoption of high-yield biotechnology-based crop systems 162

12.2.3     NUTRITIONAL QUALITY IMPROVEMENT      162

12.2.3.1  Rising focus on combating micronutrient deficiency fuels demand for biotechnology-based nutritional crop improvement  162

12.2.4     CLIMATE-RESILIENT CROPS        162

12.2.4.1  Intensifying climate variability and food security concerns drive investment in biotechnology-based resilient crop development   162

12.3       ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION            163

12.3.1     DISEASE RESISTANCE     164

12.3.1.1  Rising livestock disease outbreaks and antibiotic resistance drive adoption of genetic and molecular resistance solutions 164

12.3.2     GROWTH & PRODUCTIVITY ENHANCEMENT            164

12.3.2.1  Increasing protein demand and emission-reduction mandates promote biotechnology adoption for livestock growth and productivity enhancement       164

12.3.3     ANIMAL WELFARE SOLUTIONS     165

12.3.3.1  Rising ethical concerns and regulatory focus on humane production drive demand for biotechnology-enabled animal welfare systems 165

12.3.4     VETERINARY THERAPEUTICS       165

12.3.4.1  Growing prevalence of zoonotic diseases and advancements in biologics fuel growth of veterinary biotechnology therapeutics   165

12.4       MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION            165

12.4.1     SOIL HEALTH MANAGEMENT        167

12.4.1.1  Increasing focus on regenerative agriculture and soil restoration drives adoption of microbial soil health management technologies            167

12.4.2     PEST & DISEASE CONTROL         167

12.4.2.1  Rising pesticide restrictions and demand for organic produce drive adoption of microbial pest control solutions   167

12.4.3     SUSTAINABLE NUTRIENT CYCLING           167

12.4.3.1  Growing nutrient inefficiency and fertilizer price volatility accelerate adoption of microbial nutrient cycling technologies    167

12.4.4     BIOREMEDIATION & WASTE UTILIZATION   168

12.4.4.1  Rising agricultural waste generation and environmental pollution drive adoption of microbial bioremediation technologies 168

13         AGRICULTURE BIOTECHNOLOGY MARKET, BY TECHNOLOGY            169

13.1       INTRODUCTION  170

13.2       PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY            170

13.2.1     TISSUE CULTURE           171

13.2.1.1  Growing need for disease-free, high-quality planting materials and export-grade crops accelerates tissue culture adoption globally 171

13.2.2     SOMATIC HYBRIDIZATION            172

13.2.2.1  Advancements in cell fusion and interspecies hybridization foster innovation in developing resilient and high-yield crop hybrids     172

13.2.3     MOLECULAR DIAGNOSTICS          172

13.2.3.1  Increasing global biosecurity regulations and focus on disease-free seed trade enhance molecular diagnostic adoption in agriculture            172

13.2.4     GENETIC ENGINEERING    172

13.2.4.1  Genetic engineering represents most transformative technology in modern plant biotechnology         172

13.3       ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY            173

13.3.1     EMBRYO RESCUE & TRANSFER    174

13.3.1.1  Growing demand for genetic improvement, reproductive efficiency, and conservation drives widespread adoption of embryo transfer technologies        174

13.3.2     GENETIC ENGINEERING & CRISPR 175

13.3.2.1  Expanding use of CRISPR-Cas9 in livestock breeding drives precision genetic improvement and sustainability in animal farming            175

13.3.3     MOLECULAR DIAGNOSTICS          175

13.3.3.1  Rising livestock disease incidence and demand for rapid, accurate pathogen detection bolster molecular diagnostic adoption globally            175

13.3.4     VACCINE BIOTECHNOLOGIES       175

13.3.4.1  Rising zoonotic disease threats and focus on antibiotic-free livestock production accelerate biotech vaccine innovations globally            175

13.4       MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY            176

13.4.1     FERMENTATION TECHNOLOGY     177

13.4.1.1  Increasing use of sustainable biofertilizers and precision fermentation drives growth in microbial input production technologies            177

13.4.2     METAGENOMICS & MICROBIAL GENOMICS 178

13.4.2.1  Expanding soil microbiome research and AI-based genomic analysis accelerate innovation in precision microbial biotechnology            178

13.4.3     MOLECULAR MARKER-ASSISTED SELECTION         178

13.4.3.1  Rising need for efficient microbial strain identification promotes adoption of molecular marker-assisted selection technologies   178

13.4.4     SYNTHETIC BIOLOGY      178

13.4.4.1  Expanding investments in engineered microbes and metabolic design accelerate adoption of synthetic biology in agriculture and biotechnology      178

14         AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION            180

14.1       INTRODUCTION  181

14.2       NORTH AMERICA 184

14.2.1     US        195

14.2.1.1  Expanding bioengineering investments, AI-integrated field trials, and streamlined GMO regulations drive US biotechnology market leadership            195

14.2.2     CANADA            200

14.2.2.1  Supportive biosafety regulations and strong genomic research collaborations boost biotechnology advancement and sustainability in Canada  200

14.2.3     MEXICO 204

14.2.3.1  Expanding gene-editing research and sustainable agriculture policies accelerate biotechnology adoption and innovation in Mexico            204

14.3       EUROPE 208

14.3.1     GERMANY          219

14.3.1.1  Strong federal R&D support and industrial-scale bio-innovation reinforce Germany’s leadership in sustainable agricultural biotechnology            219

14.3.2     ITALY    223

14.3.2.1  Expanding bioinput research programs and regional sustainability initiatives accelerate biotechnology adoption in Italy’s agri-sector            223

14.3.3     FRANCE 227

14.3.3.1  Strong government R&D investment and progressive biosafety policies enhance France’s leadership in sustainable agricultural biotechnology      227

14.3.4     SPAIN   232

14.3.4.1  Expanding gene-editing research and strong government funding boost Spain’s sustainable agricultural biotechnology development            232

14.3.5     UK        236

14.3.5.1  Regulatory reforms and strong R&D investments strengthen UK’s leadership in precision agricultural biotechnology innovation      236

14.3.6     REST OF EUROPE           240

14.4       ASIA PACIFIC     245

14.4.1     CHINA   255

14.4.1.1  Expanding GMO approvals and strong state-led R&D investments reinforce China’s leadership in agricultural biotechnology innovation            255

14.4.2     INDIA     260

14.4.2.1  Government-led biotech missions and microbial innovation drive India’s agricultural transformation toward sustainable productivity growth            260

14.4.3     JAPAN  264

14.4.3.1  Strong government funding and innovation-driven industry partnerships accelerate Japan’s agricultural biotechnology advancement            264

14.4.4     AUSTRALIA & NEW ZEALAND        268

14.4.4.1  Progressive gene-editing reforms and climate-resilient R&D accelerate biotechnology growth in Australia and New Zealand   268

14.4.5     REST OF ASIA PACIFIC    273

14.5       SOUTH AMERICA 277

14.5.1     BRAZIL  287

14.5.1.1  Expanding GMO approvals and microbial innovation solidify Brazil’s leadership in agricultural biotechnology development    287

14.5.2     ARGENTINA        292

14.5.2.1  Global leadership in GM wheat and microbial bioinputs strengthens Argentina’s agricultural biotechnology innovation capacity            292

14.5.3     REST OF SOUTH AMERICA           296

14.6       REST OF THE WORLD      300

14.6.1     MIDDLE EAST     310

14.6.1.1  Government-backed innovation and food security strategies drive biotechnology adoption across Middle East’s arid regions         310

14.6.2     AFRICA 315

14.6.2.1  Expanding GM approvals and microbial innovation strengthen Africa’s resilience in sustainable agricultural biotechnology adoption            315

15         COMPETITIVE LANDSCAPE          320

15.1       OVERVIEW         320

15.2       KEY PLAYERS’ STRATEGIES, 2022–2024    320

15.3       REVENUE ANALYSIS, 2022–2024    328

15.4       MARKET SHARE ANALYSIS, 2024   331

15.5       BRAND/PRODUCT COMPARISON  335

15.5.1     BAYER AG (GERMANY)    335

15.5.2     SYNGENTA AG (SWITZERLAND)     336

15.5.3     CORTEVA (US)   336

15.5.4     ZOETIS INC. (US) 336

15.5.5     NOVONESIS GROUP (DENMARK)   336

15.6       COMPANY VALUATION AND FINANCIAL METRICS    337

15.6.1     COMPANY VALUATION    337

15.6.2     EV/EBITDA        337

15.7       PLANT BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024         338

15.7.1     STARS  338

15.7.2     EMERGING LEADERS       338

15.7.3     PERVASIVE PLAYERS      338

15.7.4     PARTICIPANTS   339

15.7.5     COMPANY FOOTPRINT: KEY PLAYERS, 2024           340

15.7.5.1  Company footprint           340

15.7.5.2  Region footprint   340

15.7.5.3  Type footprint     341

15.7.5.4  Application footprint         341

15.8       ANIMAL BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024         342

15.8.1     STARS  342

15.8.2     EMERGING LEADERS       342

15.8.3     PERVASIVE PLAYERS      342

15.8.4     PARTICIPANTS   343

15.8.5     COMPANY FOOTPRINT: KEY PLAYERS, 2024           344

15.8.5.1  Company footprint           344

15.8.5.2  Region footprint   344

15.8.5.3  Type footprint     345

15.8.5.4  Application footprint         345

15.9       MICROBIAL BIOTECHNOLOGY COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024        346

15.9.1     STARS  346

15.9.2     EMERGING LEADERS       346

15.9.3     PERVASIVE PLAYERS      346

15.9.4     PARTICIPANTS   347

15.9.5     COMPANY FOOTPRINT: KEY PLAYERS, 2024           348

15.9.5.1  Company footprint           348

15.9.5.2  Region footprint   348

15.9.5.3  Type footprint     349

15.9.5.4  Application footprint         349

15.10     COMPETITIVE SCENARIO 350

15.10.1   PRODUCT LAUNCHES     350

15.10.2   DEALS   352

15.10.3   EXPANSIONS      353

16         COMPANY PROFILES       356

16.1       PLANT BIOTECHNOLOGY COMPANIES       356

16.1.1     BASF SE            356

16.1.1.1  Business overview            356

16.1.1.2  Products/Solutions/Services offered           358

16.1.1.3  Recent developments        359

16.1.1.3.1            Product launches 359

16.1.1.3.2            Deals     360

16.1.1.3.3            Expansions          360

16.1.1.4  MnM view           361

16.1.1.4.1            Key strengths      361

16.1.1.4.2            Strategic choices 361

16.1.1.4.3            Weaknesses and competitive threats 361

16.1.2     BAYER AG         362

16.1.2.1  Business overview            362

16.1.2.2  Products/Solutions/Services offered           363

16.1.2.3  Recent developments        364

16.1.2.3.1            Product launches 364

16.1.2.3.2            Deals     365

16.1.2.3.3            Expansions          367

16.1.2.4  MnM view           367

16.1.2.4.1            Key strengths      367

16.1.2.4.2            Strategic choices 367

16.1.2.4.3            Weaknesses and competitive threats 368

16.1.3     CORTEVA AGRISCIENCE  369

16.1.3.1  Business overview            369

16.1.3.2  Products/Solutions/Services offered           370

16.1.3.3  Recent developments        372

16.1.3.3.1            Product launches 372

16.1.3.3.2            Deals     373

16.1.3.4  MnM view           375

16.1.3.4.1            Key strengths      375

16.1.3.4.2            Strategic choices 375

16.1.3.4.3            Weaknesses and competitive threats 376

16.1.4     SYNGENTA         377

16.1.4.1  Business overview            377

16.1.4.2  Products/Solutions/Services offered           378

16.1.4.3  Recent developments        381

16.1.4.3.1            Product launches 381

16.1.4.3.2            Deals     382

16.1.4.3.3            Expansions          386

16.1.4.4  MnM view           387

16.1.4.4.1            Key strengths      387

16.1.4.4.2            Strategic choices 387

16.1.4.4.3            Weaknesses and competitive threats 387

16.1.5     KWS SAAT SE & CO. KGAA           388

16.1.5.1  Business overview            388

16.1.5.2  Products/Solutions/Services offered           389

16.1.5.3  Recent developments        391

16.1.5.3.1            Product launches 391

16.1.5.3.2            Deals     391

16.1.5.3.3            Other developments         392

16.1.5.4  MnM view           392

16.1.5.4.1            Key strengths      392

16.1.5.4.2            Strategic choices 392

16.1.5.4.3            Weaknesses and competitive threats 393

16.1.6     UPL      394

16.1.6.1  Business overview            394

16.1.6.2  Products/Solutions/Services offered           395

16.1.6.3  Recent developments        397

16.1.6.3.1            Product launches 397

16.1.6.3.2            Deals     399

16.1.6.4  MnM view           400

16.1.6.4.1            Key strengths      400

16.1.6.4.2            Strategic choices 401

16.1.6.4.3            Weaknesses and competitive threats 401

16.1.7     FMC CORPORATION       402

16.1.7.1  Business overview            402

16.1.7.2  Products/Solutions/Services offered           403

16.1.7.3  Recent developments        404

16.1.7.3.1            Product launches 404

16.1.7.3.2            Deals     405

16.1.7.3.3            Expansions          407

16.1.7.3.4            Other developments         407

16.1.7.4  MnM view           408

16.1.8     SUMITOMO CHEMICAL CO., LTD.   409

16.1.8.1  Business overview            409

16.1.8.2  Products/Solutions/Services offered           410

16.1.8.3  Recent developments        410

16.1.8.3.1            Deals     410

16.1.8.3.2            Expansions          411

16.1.8.4  MnM view           412

16.1.9     NUFARM            413

16.1.9.1  Business overview            413

16.1.9.2  Products/Solutions/Services offered           414

16.1.9.3  Recent developments        415

16.1.9.3.1            Product launches 415

16.1.9.3.2            Deals     415

16.1.9.4  MnM view           416

16.1.10   PRO FARM GROUP          417

16.1.10.1 Business overview            417

16.1.10.2 Products/Solutions/Services offered           418

16.1.10.3 Recent developments        419

16.1.10.3.1           Product launches 419

16.1.10.4 MnM view           419

16.2       ANIMAL BIOTECHNOLOGY COMPANIES     420

16.2.1     ZOETIS SERVICES LLC    420

16.2.1.1  Business overview            420

16.2.1.2  Products/Solutions/Services offered           421

16.2.1.3  Recent developments        422

16.2.1.3.1            Other developments         422

16.2.1.3.2            Expansions          422

16.2.1.4  MnM view           423

16.2.1.4.1            Key strengths      423

16.2.1.4.2            Strategic choices 423

16.2.1.4.3            Weaknesses and competitive threats 423

16.2.2     ELANCO OR ITS AFFILIATES         424

16.2.2.1  Business overview            424

16.2.2.2  Products/Solutions/Services offered           425

16.2.2.3  Recent developments        426

16.2.2.3.1            Product launches 426

16.2.2.4  MnM view           426

16.2.2.4.1            Key strengths      426

16.2.2.4.2            Strategic choices 427

16.2.2.4.3            Weaknesses and competitive threats 427

16.2.3     MERCK & CO., INC.          428

16.2.3.1  Business overview            428

16.2.3.2  Products/Solutions/Services offered           429

16.2.3.3  Recent developments        430

16.2.3.3.1            Expansions          430

16.2.3.4  MnM view           430

16.2.3.4.1            Key strengths      430

16.2.3.4.2            Strategic choices 430

16.2.3.4.3            Weaknesses and competitive threats 431

16.2.4     CEVA    432

16.2.4.1  Business overview            432

16.2.4.2  Products/Solutions/Services offered           432

16.2.4.3  Recent developments        433

16.2.4.3.1            Expansions          433

16.2.4.4  MnM view           434

16.2.5     VIRBAC 435

16.2.5.1  Business overview            435

16.2.5.2  Products/Solutions/Services offered           436

16.2.5.3  Recent developments        437

16.2.5.3.1            Product launches 437

16.2.5.4  MnM view           437

16.2.5.4.1            Key strengths      437

16.2.5.4.2            Strategic choices 437

16.2.5.4.3            Weaknesses and competitive threats 438

16.2.6     HESTER BIOSCIENCES LIMITED    439

16.2.6.1  Business overview            439

16.2.6.2  Products/Solutions/Services offered           440

16.2.6.3  MnM view           441

16.2.7     GENUS PLC       442

16.2.7.1  Business overview            442

16.2.7.2  Products/Solutions/Services offered           443

16.2.7.3  MnM view           444

16.2.8     VAXXINOVA       445

16.2.8.1  Business overview            445

16.2.8.2  Products/Solutions/Services offered           445

16.2.8.3  MnM view           446

16.2.9     AB VISTA           447

16.2.9.1  Business overview            447

16.2.9.2  Products/Solutions/Services offered           447

16.2.9.3  MnM view           448

16.2.10   BOEHRINGER INGELHEIM INTERNATIONAL GMBH    449

16.2.10.1 Business overview            449

16.2.10.2 Products/Solutions/Services offered           450

16.2.10.3 Recent developments        451

16.2.10.3.1           Product launches 451

16.2.10.4 MnM view           452

16.2.10.4.1           Key strengths      452

16.2.10.4.2           Strategic choices 452

16.2.10.4.3           Weaknesses and competitive threats 452

16.3       MICROBE BIOTECHNOLOGY COMPANIES   453

16.3.1     VALENT U.S.A. LLC         453

16.3.1.1  Business overview            453

16.3.1.2  Products/Solutions/Services offered           454

16.3.1.3  Recent developments        455

16.3.1.3.1            Deals     455

16.3.1.3.2            Expansions          455

16.3.1.4  MnM view           455

16.3.1.4.1            Key strengths      455

16.3.1.4.2            Strategic choices 456

16.3.1.4.3            Weaknesses and competitive threats 456

16.3.2     NOVONESIS GROUP        457

16.3.2.1  Business overview            457

16.3.2.2  Products/Solutions/Services offered           458

16.3.2.3  Recent developments        459

16.3.2.3.1            Product launches 459

16.3.2.3.2            Deals     459

16.3.2.3.3            Expansions          460

16.3.2.4  MnM view           460

16.3.2.4.1            Key strengths      460

16.3.2.4.2            Strategic choices 460

16.3.2.4.3            Weaknesses and competitive threats 461

16.3.3     INDIGO AG, INC.  462

16.3.3.1  Business overview            462

16.3.3.2  Products/Solutions/Services offered           463

16.3.3.3  Recent developments        464

16.3.3.3.1            Product launches 464

16.3.3.3.2            Deals     464

16.3.3.3.3            Expansions          465

16.3.3.4  MnM view           465

16.3.3.4.1            Key strengths      465

16.3.3.4.2            Strategic choices 465

16.3.3.4.3            Weaknesses and competitive threats 465

16.3.4     PIVOT BIO         466

16.3.4.1  Business overview            466

16.3.4.2  Products/Solutions/Services offered           467

16.3.4.3  Recent developments        467

16.3.4.3.1            Other developments         467

16.3.4.3.2            Expansions          468

16.3.4.4  MnM view           468

16.3.4.4.1            Key strengths      468

16.3.4.4.2            Strategic choices 469

16.3.4.4.3            Weaknesses and competitive threats 469

16.3.5     BIOATLANTIS LTD.          470

16.3.5.1  Business overview            470

16.3.5.2  Products/Solutions/Services offered           471

16.3.5.3  Recent developments        471

16.3.5.3.1            Product launches 471

16.3.5.3.2            Deals     472

16.3.5.4  MnM view           472

16.3.5.4.1            Key strengths      472

16.3.5.4.2            Strategic choices 473

16.3.5.4.3            Weaknesses and competitive threats 473

16.3.6     CERTIS USA L.L.C.           474

16.3.6.1  Business overview            474

16.3.6.2  Products/Solutions/Services offered           475

16.3.6.3  Recent developments        477

16.3.6.3.1            Product launches 477

16.3.6.3.2            Deals     477

16.3.6.4  MnM view           477

16.3.7     ZYMOLENT BIOSCIENCES PVT. LTD.          478

16.3.7.1  Business overview            478

16.3.7.2  Products/Solutions/Services offered           479

16.3.7.3  Recent developments        479

16.3.7.3.1            Other developments         479

16.3.7.4  MnM view           479

16.3.8     AGRICEN           480

16.3.8.1  Business overview            480

16.3.8.2  Products/Solutions/Services offered           481

16.3.8.3  Recent developments        481

16.3.8.3.1            Deals     481

16.3.8.4  MnM view           482

16.3.9     VARSHA BIOSCIENCE AND TECHNOLOGY INDIA PVT LTD.            483

16.3.9.1  Business overview            483

16.3.9.2  Products/Solutions/Services offered           484

16.3.9.3  Recent developments        486

16.3.9.4  MnM view           486

16.3.10   GROUNDWORK BIOAG     487

16.3.10.1 Business overview            487

16.3.10.2 Products/Solutions/Services offered           488

16.3.10.3 Recent developments        489

16.3.10.3.1           Product launches 489

16.3.10.3.2           Deals     489

16.3.10.4 MnM view           490

17         ADJACENT AND RELATED MARKETS         491

17.1       INTRODUCTION  491

17.2       LIMITATIONS      491

17.3       PLANT BIOTECHNOLOGY MARKET            491

17.3.1     MARKET DEFINITION        491

17.3.2     MARKET OVERVIEW         492

17.4       AGRICULTURAL MICROBIALS MARKET      493

17.4.1     MARKET DEFINITION        493

17.4.2     AGRICULTURAL MICROBIALS MARKET, BY APPLICATION            493

18         APPENDIX          495

18.1       DISCUSSION GUIDE         495

18.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL  503

18.3       CUSTOMIZATION OPTIONS          505

18.4       RELATED REPORTS        506

18.5       AUTHOR DETAILS           506

LIST OF TABLES

TABLE 1 USD EXCHANGE RATES, 2020–2024           50

TABLE 2 AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT, 2025 VS. 2030 65

TABLE 3 AGRICULTURE BIOTECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS         87

TABLE 4 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR PLANT BIOTECHNOLOGY 95

TABLE 5 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR MICROBIAL BIOTECHNOLOGY      96

TABLE 6 INDICATIVE PRICING ANALYSIS BY KEY COMPANIES FOR ANIMAL BIOTECHNOLOGY           96

TABLE 7 PLANT BIOTECHNOLOGY – INDICATIVE REGIONAL PRICING, 2024      97

TABLE 8 MICROBIAL BIOTECHNOLOGY – INDICATIVE REGIONAL PRICING, 2024    98

TABLE 9 ANIMAL BIOTECHNOLOGY – INDICATIVE REGIONAL PRICING, 2024      98

TABLE 10           TOP 10 EXPORTERS OF HS CODE 382100, 2020–2024 (USD THOUSAND)           101

TABLE 11           TOP 10 IMPORTERS OF HS CODE 382100, 2020–2024 (USD THOUSAND)           102

TABLE 12           TOP 10 EXPORTERS OF HS CODE 382100, 2020–2024 (TONS)  102

TABLE 13           TOP 10 IMPORTERS OF HS CODE 382100, 2020–2024 (TONS)  103

TABLE 14           AGRICULTURE BIOTECHNOLOGY MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026     103

TABLE 15           US-ADJUSTED RECIPROCAL TARIFF RATES            108

TABLE 16           EXPECTED IMPACT LEVEL ON TARGET PRODUCTS WITH RELEVANT HS CODES DUE TO TRUMP TARIFF IMPACT            109

TABLE 17           EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES       110

TABLE 18           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AGRICULTURE BIOTECHNOLOGY TYPE        113

TABLE 19           KEY BUYING CRITERIA FOR AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE        114

TABLE 20           LIST OF MAJOR PATENTS FOR AGRICULTURE BIOTECHNOLOGY MARKET,

2021–2024          120

TABLE 21           NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS       130

TABLE 22           EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS       131

TABLE 23           ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS       131

TABLE 24           SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS       132

TABLE 25           MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS            132

TABLE 26           AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM,

2020–2024 (USD MILLION) 138

TABLE 27           AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM,

2025–2030 (USD MILLION) 139

TABLE 28           PLANTS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION,

2020–2024 (USD MILLION) 139

TABLE 29           PLANTS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION,

2025–2030 (USD MILLION) 140

TABLE 30          ANIMALS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION,

2020–2024 (USD MILLION) 141

TABLE 31          ANIMALS: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION,

2025–2030 (USD MILLION) 141

TABLE 32           MICROBIAL: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION,

2020–2024 (USD MILLION) 142

TABLE 33           MICROBIAL: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION,

2025–2030 (USD MILLION) 142

TABLE 34           PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)        145

TABLE 35           PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)        145

TABLE 36           CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET,

BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)          146

TABLE 37           CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET,

BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)          146

TABLE 38           CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET,

BY REGION, 2020-2024 (THOUSAND METRIC TONS) 146

TABLE 39           CROP PROTECTION & SOIL ENHANCEMENT: PLANT BIOTECHNOLOGY MARKET,

BY REGION, 2025-2030 (THOUSAND METRIC TONS) 147

TABLE 40           BIOPESTICIDES: PLANT BIOTECHNOLOGY MARKET, BY REGION,

2020-2024 (THOUSAND METRIC TONS)      147

TABLE 41           BIOPESTICIDES: PLANT BIOTECHNOLOGY MARKET, BY REGION,

2025-2030 (THOUSAND METRIC TONS)      147

TABLE 42           BIOFERTILIZERS: PLANT BIOTECHNOLOGY MARKET, BY REGION,

2020-2024 (THOUSAND METRIC TONS)      148

TABLE 43           BIOFERTILIZERS: PLANT BIOTECHNOLOGY MARKET, BY REGION,

2025-2030 (THOUSAND METRIC TONS)      148

TABLE 44           PLANT GROWTH REGULATORS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)   148

TABLE 45           PLANT GROWTH REGULATORS: PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)   149

TABLE 46           ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)        151

TABLE 47           ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)        152

TABLE 48           MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 154

TABLE 49           MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 154

TABLE 50           MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020-2024

(THOUSAND METRIC TONS)         155

TABLE 51           MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025-2030

(THOUSAND METRIC TONS)         155

TABLE 52           MICROBIAL BIOFERTILIZERS & MICROBIAL BIOSTIMULANTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2020-2024 (THOUSAND METRIC TONS)      156

TABLE 53           MICROBIAL BIOFERTILIZERS & MICROBIAL BIOSTIMULANTS: AGRICULTURAL MICROBIALS MARKET, BY REGION, 2025-2030 (THOUSAND METRIC TONS)      156

TABLE 54           MICROBIAL BIOCONTROL AGENTS: AGRICULTURAL MICROBIALS MARKET,

BY REGION, 2020-2024 (THOUSAND METRIC TONS) 157

TABLE 55           MICROBIAL BIOCONTROL AGENTS: AGRICULTURAL MICROBIALS MARKET,

BY REGION, 2025-2030 (THOUSAND METRIC TONS) 157

TABLE 56           PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)    161

TABLE 57           PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)    161

TABLE 58           ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)    163

TABLE 59           ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)    164

TABLE 60           MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 166

TABLE 61           MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 166

TABLE 62           PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)   171

TABLE 63           PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)   171

TABLE 64           ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)   174

TABLE 65           ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)   174

TABLE 66           MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 177

TABLE 67           MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 177

TABLE 68           AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 182

TABLE 69           AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 182

TABLE 70           PLANT BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 182

TABLE 71           PLANT BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 183

TABLE 72           ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 183

TABLE 73           ANIMAL BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 183

TABLE 74           MICROBIAL BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION) 184

TABLE 75           MICROBIAL BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION) 184

TABLE 76           NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 185

TABLE 77           NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 186

TABLE 78          NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 186

TABLE 79          NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 186

TABLE 80          NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 187

TABLE 81          NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 187

TABLE 82           NORTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)  187

TABLE 83           NORTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)  188

TABLE 84          NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 188

TABLE 85          NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 188

TABLE 86          NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 189

TABLE 87          NORTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 189

TABLE 88           NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 189

TABLE 89           NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 190

TABLE 90           NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 190

TABLE 91           NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 190

TABLE 92           NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 191

TABLE 93           NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 191

TABLE 94           NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 191

TABLE 95           NORTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 192

TABLE 96           NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION)           192

TABLE 97           NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 192

TABLE 98           NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 193

TABLE 99           NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 193

TABLE 100         NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020-2024 (THOUSAND METRIC TONS)      193

TABLE 101         NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025-2030 (THOUSAND METRIC TONS)      194

TABLE 102         NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 194

TABLE 103         NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 194

TABLE 104         NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 195

TABLE 105         NORTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 195

TABLE 106         US: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 196

TABLE 107         US: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 196

TABLE 108         US: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 196

TABLE 109         US: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 197

TABLE 110         US: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 197

TABLE 111         US: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 197

TABLE 112         US: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 198

TABLE 113         US: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 198

TABLE 114        US: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 198

TABLE 115        US: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 199

TABLE 116         US: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 199

TABLE 117         US: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 199

TABLE 118         CANADA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)    200

TABLE 119         CANADA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)    200

TABLE 120         CANADA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 201

TABLE 121         CANADA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 201

TABLE 122         CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)    201

TABLE 123         CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)    202

TABLE 124         CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 202

TABLE 125         CANADA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 202

TABLE 126         CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 203

TABLE 127         CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 203

TABLE 128         CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 203

TABLE 129         CANADA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 204

TABLE 130         MEXICO: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)    204

TABLE 131         MEXICO: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)    205

TABLE 132         MEXICO: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 205

TABLE 133         MEXICO: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 205

TABLE 134         MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)    206

TABLE 135         MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)    206

TABLE 136         MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 206

TABLE 137         MEXICO: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 207

TABLE 138         MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 207

TABLE 139         MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 207

TABLE 140         MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 208

TABLE 141         MEXICO: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 208

TABLE 142         EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 209

TABLE 143         EUROPE: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 209

TABLE 144         EUROPE: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION)           209

TABLE 145         EUROPE: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 210

TABLE 146         EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)    210

TABLE 147         EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)    210

TABLE 148         EUROPEAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)  211

TABLE 149         EUROPEAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)  211

TABLE 150         EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 211

TABLE 151         EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 212

TABLE 152         EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 212

TABLE 153         EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 212

TABLE 154         EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 213

TABLE 155         EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 213

TABLE 156         EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)    213

TABLE 157         EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)    214

TABLE 158         EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 214

TABLE 159         EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 214

TABLE 160         EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 215

TABLE 161         EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 215

TABLE 162         EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 215

TABLE 163         EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 216

TABLE 164         EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 216

TABLE 165         EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 216

TABLE 166         EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020-2024 (THOUSAND METRIC TONS)      217

TABLE 167         EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025-2030 (THOUSAND METRIC TONS)      217

TABLE 168         EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 217

TABLE 169         EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 218

TABLE 170         EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 218

TABLE 171         EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 218

TABLE 172         GERMANY: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 219

TABLE 173         GERMANY: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 219

TABLE 174         GERMANY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 220

TABLE 175         GERMANY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 220

TABLE 176         GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 220

TABLE 177         GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 221

TABLE 178         GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 221

TABLE 179         GERMANY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 221

TABLE 180         GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 222

TABLE 181         GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 222

TABLE 182         GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 222

TABLE 183         GERMANY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 223

TABLE 184         ITALY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 223

TABLE 185         ITALY: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 224

TABLE 186         ITALY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 224

TABLE 187         ITALY: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 224

TABLE 188         ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 225

TABLE 189         ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 225

TABLE 190         ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 225

TABLE 191         ITALY: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 226

TABLE 192         ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 226

TABLE 193         ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 226

TABLE 194         ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 227

TABLE 195         ITALY: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 227

TABLE 196         FRANCE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)    228

TABLE 197         FRANCE: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)    228

TABLE 198         FRANCE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 228

TABLE 199         FRANCE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 229

TABLE 200         FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)    229

TABLE 201         FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)    229

TABLE 202         FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 230

TABLE 203         FRANCE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 230

TABLE 204         FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 230

TABLE 205         FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 231

TABLE 206         FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 231

TABLE 207         FRANCE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 231

TABLE 208         SPAIN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 232

TABLE 209         SPAIN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 232

TABLE 210         SPAIN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 233

TABLE 211         SPAIN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 233

TABLE 212        SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 233

TABLE 213        SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 234

TABLE 214         SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 234

TABLE 215         SPAIN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 234

TABLE 216         SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 235

TABLE 217         SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 235

TABLE 218         SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 235

TABLE 219         SPAIN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 236

TABLE 220         UK: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 236

TABLE 221         UK: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 237

TABLE 222         UK: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 237

TABLE 223         UK: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 237

TABLE 224         UK: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 238

TABLE 225         UK: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 238

TABLE 226         UK: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 238

TABLE 227         UK: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 239

TABLE 228        UK: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 239

TABLE 229        UK: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 239

TABLE 230         UK: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 240

TABLE 231         UK: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 240

TABLE 232         REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 241

TABLE 233         REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 241

TABLE 234         REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 241

TABLE 235         REST OF EUROPE: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 242

TABLE 236         REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 242

TABLE 237         REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 242

TABLE 238         REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 243

TABLE 239         REST OF EUROPE: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 243

TABLE 240         REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 243

TABLE 241         REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 244

TABLE 242         REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 244

TABLE 243         REST OF EUROPE: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 244

TABLE 244         ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 246

TABLE 245         ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 246

TABLE 246         ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 246

TABLE 247         ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 247

TABLE 248         ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 247

TABLE 249         ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 247

TABLE 250         ASIA PACIFIC CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)  248

TABLE 251         ASIA PACIFIC CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)  248

TABLE 252         ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 248

TABLE 253         ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 249

TABLE 254         ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 249

TABLE 255         ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 249

TABLE 256         ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 250

TABLE 257         ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 250

TABLE 258         ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 250

TABLE 259         ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 251

TABLE 260         ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION)           251

TABLE 261         ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 251

TABLE 262         ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 252

TABLE 263         ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 252

TABLE 264         ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 252

TABLE 265         ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 253

TABLE 266         ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 253

TABLE 267         ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 253

TABLE 268         ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020-2024 (THOUSAND METRIC TONS)      254

TABLE 269         ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025-2030 (THOUSAND METRIC TONS)      254

TABLE 270         ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 254

TABLE 271         ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 254

TABLE 272         ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 255

TABLE 273         ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 255

TABLE 274         CHINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 256

TABLE 275         CHINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 256

TABLE 276         CHINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 256

TABLE 277         CHINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 257

TABLE 278        CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 257

TABLE 279        CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 257

TABLE 280         CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 258

TABLE 281         CHINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 258

TABLE 282         CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 258

TABLE 283         CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 259

TABLE 284         CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 259

TABLE 285         CHINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 259

TABLE 286         INDIA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 260

TABLE 287         INDIA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 260

TABLE 288         INDIA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 261

TABLE 289         INDIA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION)           261

TABLE 290         INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 261

TABLE 291         INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 262

TABLE 292         INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 262

TABLE 293         INDIA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 262

TABLE 294         INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 263

TABLE 295         INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 263

TABLE 296         INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 263

TABLE 297         INDIA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 264

TABLE 298         JAPAN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 264

TABLE 299         JAPAN: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 265

TABLE 300         JAPAN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 265

TABLE 301         JAPAN: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 265

TABLE 302         JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)    266

TABLE 303         JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)    266

TABLE 304         JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 266

TABLE 305         JAPAN: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 267

TABLE 306         JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 267

TABLE 307         JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 267

TABLE 308         JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 268

TABLE 309         JAPAN: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 268

TABLE 310         AUSTRALIA & NEW ZEALAND: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 269

TABLE 311         AUSTRALIA & NEW ZEALAND: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 269

TABLE 312         AUSTRALIA & NEW ZEALAND: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)            269

TABLE 313         AUSTRALIA & NEW ZEALAND: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)            270

TABLE 314         AUSTRALIA & NEW ZEALAND: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION)           270

TABLE 315         AUSTRALIA & NEW ZEALAND: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 270

TABLE 316         AUSTRALIA & NEW ZEALAND: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)            271

TABLE 317         AUSTRALIA & NEW ZEALAND: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)            271

TABLE 318         AUSTRALIA & NEW ZEALAND: MICROBIAL BIOTECHNOLOGY MARKET,

BY TYPE, 2020–2024 (USD MILLION)           271

TABLE 319         AUSTRALIA & NEW ZEALAND: MICROBIAL BIOTECHNOLOGY MARKET,

BY TYPE, 2025–2030 (USD MILLION)           272

TABLE 320         AUSTRALIA & NEW ZEALAND: MICROBIAL BIOTECHNOLOGY MARKET,

BY APPLICATION, 2020–2024 (USD MILLION)           272

TABLE 321         AUSTRALIA & NEW ZEALAND: MICROBIAL BIOTECHNOLOGY MARKET,

BY APPLICATION, 2025–2030 (USD MILLION)           272

TABLE 322         REST OF ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 273

TABLE 323         REST OF ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 273

TABLE 324         REST OF ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 274

TABLE 325         REST OF ASIA PACIFIC: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 274

TABLE 326         REST OF ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 274

TABLE 327         REST OF ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 275

TABLE 328         REST OF ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)         275

TABLE 329         REST OF ASIA PACIFIC: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)         275

TABLE 330         REST OF ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 276

TABLE 331         REST OF ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 276

TABLE 332         REST OF ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)            276

TABLE 333         REST OF ASIA PACIFIC: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)            277

TABLE 334         SOUTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 277

TABLE 335         SOUTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 278

TABLE 336        SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 278

TABLE 337        SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 278

TABLE 338        SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 279

TABLE 339        SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 279

TABLE 340         SOUTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024 (THOUSAND METRIC TONS)  279

TABLE 341         SOUTH AMERICAN CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030 (THOUSAND METRIC TONS)  280

TABLE 342        SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 280

TABLE 343        SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 280

TABLE 344        SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 281

TABLE 345        SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION)           281

TABLE 346         SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 281

TABLE 347         SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 282

TABLE 348         SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 282

TABLE 349         SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 282

TABLE 350         SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 283

TABLE 351         SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 283

TABLE 352         SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 283

TABLE 353         SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 284

TABLE 354         SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2020–2024 (USD MILLION) 284

TABLE 355         SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY COUNTRY,

2025–2030 (USD MILLION) 284

TABLE 356         SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 285

TABLE 357         SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 285

TABLE 358         SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020-2024 (THOUSAND METRIC TONS)      285

TABLE 359         SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025-2030 (THOUSAND METRIC TONS)      286

TABLE 360         SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 286

TABLE 361         SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 286

TABLE 362         SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 287

TABLE 363         SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 287

TABLE 364        BRAZIL: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION) 288

TABLE 365        BRAZIL: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION) 288

TABLE 366         BRAZIL: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 288

TABLE 367         BRAZIL: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 289

TABLE 368         BRAZIL: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)    289

TABLE 369         BRAZIL: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)    289

TABLE 370         BRAZIL: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 290

TABLE 371         BRAZIL: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 290

TABLE 372         BRAZIL: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 290

TABLE 373         BRAZIL: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 291

TABLE 374         BRAZIL: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 291

TABLE 375         BRAZIL: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 291

TABLE 376         ARGENTINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 292

TABLE 377         ARGENTINA: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 292

TABLE 378         ARGENTINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 293

TABLE 379         ARGENTINA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 293

TABLE 380         ARGENTINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 293

TABLE 381         ARGENTINA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION)           294

TABLE 382         ARGENTINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 294

TABLE 383         ARGENTINA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 294

TABLE 384         ARGENTINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 295

TABLE 385         ARGENTINA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 295

TABLE 386         ARGENTINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 295

TABLE 387         ARGENTINA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 296

TABLE 388         REST OF SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 296

TABLE 389         REST OF SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 297

TABLE 390         REST OF SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)            297

TABLE 391         REST OF SOUTH AMERICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)            297

TABLE 392         REST OF SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 298

TABLE 393         REST OF SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 298

TABLE 394         REST OF SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)            298

TABLE 395         REST OF SOUTH AMERICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)            299

TABLE 396         REST OF SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 299

TABLE 397         REST OF SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 299

TABLE 398         REST OF SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET,

BY APPLICATION, 2020–2024 (USD MILLION)           300

TABLE 399         REST OF SOUTH AMERICA: MICROBIAL BIOTECHNOLOGY MARKET,

BY APPLICATION, 2025–2030 (USD MILLION)           300

TABLE 400         REST OF THE WORLD: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2020–2024 (USD MILLION)            301

TABLE 401         REST OF THE WORLD: AGRICULTURE BIOTECHNOLOGY MARKET, BY REGION, 2025–2030 (USD MILLION)            301

TABLE 402         REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY REGION,

2020–2024 (USD MILLION) 301

TABLE 403         REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY REGION,

2025–2030 (USD MILLION) 301

TABLE 404         REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 302

TABLE 405         REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 302

TABLE 406         REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2020–2024 (USD MILLION) 302

TABLE 407         REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025–2030 (USD MILLION) 303

TABLE 408         REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 303

TABLE 409         REST OF THE WORLD: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 303

TABLE 410         REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY REGION,

2020–2024 (USD MILLION) 304

TABLE 411         REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY REGION,

2025–2030 (USD MILLION) 304

TABLE 412         REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 304

TABLE 413         REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 305

TABLE 414         REST OF THE WORLD CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2020-2024

(THOUSAND METRIC TONS)         305

TABLE 415         REST OF THE WORLD CROP PROTECTION & SOIL ENHANCEMENT PRODUCTS: PLANT BIOTECHNOLOGY MARKET, BY PRODUCT, 2025-2030

(THOUSAND METRIC TONS)         305

TABLE 416         REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)         306

TABLE 417         REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)         306

TABLE 418         REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 306

TABLE 419         REST OF THE WORLD: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 307

TABLE 420         REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY REGION,

2020–2024 (USD MILLION) 307

TABLE 421         REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY REGION,

2025–2030 (USD MILLION) 307

TABLE 422         REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 308

TABLE 423         REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 308

TABLE 424         REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020-2024 (THOUSAND METRIC TONS)      308

TABLE 425         REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025-2030 (THOUSAND METRIC TONS)      309

TABLE 426         REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2020–2024 (USD MILLION)         309

TABLE 427         REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)         309

TABLE 428         REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2020–2024 (USD MILLION)         310

TABLE 429         REST OF THE WORLD: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION, 2025–2030 (USD MILLION)         310

TABLE 430         MIDDLE EAST: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 311

TABLE 431         MIDDLE EAST: PLANT BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 311

TABLE 432         MIDDLE EAST: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 311

TABLE 433         MIDDLE EAST: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 312

TABLE 434         MIDDLE EAST: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 312

TABLE 435         MIDDLE EAST: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 312

TABLE 436         MIDDLE EAST: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 313

TABLE 437         MIDDLE EAST: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 313

TABLE 438         MIDDLE EAST: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 313

TABLE 439         MIDDLE EAST: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 314

TABLE 440         MIDDLE EAST: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 314

TABLE 441         MIDDLE EAST: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 314

TABLE 442         AFRICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)    315

TABLE 443         AFRICA: PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)    315

TABLE 444         AFRICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 316

TABLE 445         AFRICA: PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 316

TABLE 446         AFRICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2020–2024 (USD MILLION)    316

TABLE 447         AFRICA: ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025–2030 (USD MILLION)    317

TABLE 448         AFRICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 317

TABLE 449         AFRICA: ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 317

TABLE 450         AFRICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2020–2024 (USD MILLION) 318

TABLE 451         AFRICA: MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE,

2025–2030 (USD MILLION) 318

TABLE 452         AFRICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2020–2024 (USD MILLION) 318

TABLE 453         AFRICA: MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 319

TABLE 454         COMPETITIVE STRATEGY INITIATIVES (PLANT BIOTECHNOLOGY MARKET)         321

TABLE 455         COMPETITIVE STRATEGY INITIATIVES (ANIMAL BIOTECHNOLOGY MARKET)         324

TABLE 456         COMPETITIVE STRATEGY INITIATIVES (MICROBIAL BIOTECHNOLOGY MARKET)         326

TABLE 457         PLANT BIOTECHNOLOGY MARKET: DEGREE OF COMPETITION    332

TABLE 458         ANIMAL BIOTECHNOLOGY MARKET: DEGREE OF COMPETITION    333

TABLE 459         MICROBIAL BIOTECHNOLOGY MARKET: DEGREE OF COMPETITION    334

TABLE 460         PLANT BIOTECHNOLOGY MARKET: REGION FOOTPRINT       340

TABLE 461         PLANT BIOTECHNOLOGY MARKET: TYPE FOOTPRINT       341

TABLE 462         PLANT BIOTECHNOLOGY MARKET: APPLICATION FOOTPRINT       341

TABLE 463         ANIMAL BIOTECHNOLOGY MARKET: REGION FOOTPRINT       344

TABLE 464         ANIMAL BIOTECHNOLOGY MARKET: TYPE FOOTPRINT       345

TABLE 465         ANIMAL BIOTECHNOLOGY MARKET: APPLICATION FOOTPRINT       345

TABLE 466         MICROBIAL BIOTECHNOLOGY MARKET: REGION FOOTPRINT       348

TABLE 467         MICROBIAL BIOTECHNOLOGY MARKET: TYPE FOOTPRINT       349

TABLE 468         MICROBIAL BIOTECHNOLOGY MARKET: APPLICATION FOOTPRINT           349

TABLE 469         AGRICULTURE BIOTECHNOLOGY MARKET: PRODUCT LAUNCHES,

MARCH 2021–SEPTEMBER 2025    350

TABLE 470         AGRICULTURE BIOTECHNOLOGY MARKET: DEALS, JULY 2023–AUGUST 2025 352

TABLE 471         AGRICULTURE BIOTECHNOLOGY MARKET: EXPANSIONS, JULY 2021–MAY 2025          354

TABLE 472         BASF SE: COMPANY OVERVIEW    357

TABLE 473         BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED           358

TABLE 474         BASF SE: PRODUCT LAUNCHES    359

TABLE 475         BASF SE: DEALS 360

TABLE 476         BASF SE: EXPANSIONS    360

TABLE 477         BAYER AG: COMPANY OVERVIEW  362

TABLE 478         BAYER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED           363

TABLE 479         BAYER AG: PRODUCT LAUNCHES 364

TABLE 480         BAYER AG: DEALS          365

TABLE 481         BAYER AG: EXPANSIONS 367

TABLE 482         CORTEVA AGRISCIENCE: COMPANY OVERVIEW            369

TABLE 483         CORTEVA AGRISCIENCE: PRODUCTS/SOLUTIONS/SERVICES OFFERED        370

TABLE 484         CORTEVA AGRISCIENCE: PRODUCT LAUNCHES            372

TABLE 485         CORTEVA AGRISCIENCE: DEALS   373

TABLE 486         SYNGENTA: COMPANY OVERVIEW 377

TABLE 487         SYNGENTA: PRODUCTS/SOLUTIONS/SERVICES OFFERED           378

TABLE 488         SYNGENTA: PRODUCT LAUNCHES 381

TABLE 489         SYNGENTA: DEALS          382

TABLE 490         SYNGENTA: EXPANSIONS 386

TABLE 491         KWS SAAT SE & CO. KGAA: COMPANY OVERVIEW            388

TABLE 492         KWS SAAT SE & CO. KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED        389

TABLE 493         KWS SAAT SE & CO. KGAA: PRODUCT LAUNCHES            391

TABLE 494         KWS SAAT SE & CO. KGAA: DEALS            391

TABLE 495         KWS SAAT SE & CO. KGAA: OTHER DEVELOPMENTS            392

TABLE 496         UPL: COMPANY OVERVIEW           394

TABLE 497         UPL: PRODUCTS/SOLUTIONS/SERVICES OFFERED            395

TABLE 498         UPL: PRODUCT LAUNCHES          397

TABLE 499         UPL: DEALS       399

TABLE 500         FMC CORPORATION: COMPANY OVERVIEW            402

TABLE 501         FMC CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED        403

TABLE 502         FMC CORPORATION: PRODUCT LAUNCHES            404

TABLE 503         FMC CORPORATION: DEALS         405

TABLE 504         FMC CORPORATION: EXPANSIONS            407

TABLE 505         FMC CORPORATION: OTHER DEVELOPMENTS            407

TABLE 506         SUMITOMO CHEMICAL CO., LTD.: COMPANY OVERVIEW         409

TABLE 507         SUMITOMO CHEMICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED        410

TABLE 508         SUMITOMO CHEMICAL CO., LTD.: DEALS    410

TABLE 509         SUMITOMO CHEMICAL CO., LTD.: EXPANSIONS            411

TABLE 510         NUFARM: COMPANY OVERVIEW    413

TABLE 511         NUFARM: PRODUCTS/SOLUTIONS/SERVICES OFFERED           414

TABLE 512         NUFARM: PRODUCT LAUNCHES    415

TABLE 513         NUFARM: DEALS 415

TABLE 514         PRO FARM GROUP: COMPANY OVERVIEW  417

TABLE 515         PRO FARM GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED        418

TABLE 516         PRO FARM GROUP: PRODUCT LAUNCHES  419

TABLE 517         ZOETIS INC.: COMPANY OVERVIEW            420

TABLE 518         ZOETIS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED           421

TABLE 519         ZOETIS INC.: OTHER DEVELOPMENTS        422

TABLE 520         ZOETIS INC: EXPANSIONS            422

TABLE 521         ELANCO OR ITS AFFILIATES: COMPANY OVERVIEW            424

TABLE 522         ELANCO OR ITS AFFILIATES: PRODUCTS/SOLUTIONS/SERVICES OFFERED        425

TABLE 523         ELANCO OR ITS AFFILIATES: PRODUCT LAUNCHES            426

TABLE 524         MERCK & CO., INC.: COMPANY OVERVIEW  428

TABLE 525         MERCK & CO., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED        429

TABLE 526         MERCK & CO., INC.: EXPANSIONS  430

TABLE 527         CEVA: COMPANY OVERVIEW        432

TABLE 528         CEVA: PRODUCTS/SOLUTIONS/SERVICES OFFERED           432

TABLE 529         CEVA: EXPANSIONS        433

TABLE 530         VIRBAC: COMPANY OVERVIEW     435

TABLE 531         VIRBAC: PRODUCTS/SOLUTIONS/SERVICES OFFERED           436

TABLE 532         VIRBAC: PRODUCT LAUNCHES     437

TABLE 533         HESTER BIOSCIENCES LIMITED: COMPANY OVERVIEW         439

TABLE 534         HESTER BIOSCIENCES LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED        440

TABLE 535         GENUS PLC: COMPANY OVERVIEW            442

TABLE 536         GENUS PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED           443

TABLE 537         VAXXINOVA: COMPANY OVERVIEW            445

TABLE 538         VAXXINOVA: PRODUCTS/SOLUTIONS/SERVICES OFFERED           445

TABLE 539         AB VISTA: COMPANY OVERVIEW   447

TABLE 540         AB VISTA: PRODUCTS/SOLUTIONS/SERVICES OFFERED           447

TABLE 541         BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW      449

TABLE 542         BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED        450

TABLE 543         BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT LAUNCHES     451

TABLE 544         VALENT U.S.A. LLC: COMPANY OVERVIEW  453

TABLE 545         VALENT U.S.A. LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED        454

TABLE 546         VALENT U.S.A. LLC: DEALS           455

TABLE 547         VALENT U.S.A. LLC: EXPANSIONS  455

TABLE 548         NOVONESIS GROUP: COMPANY OVERVIEW 457

TABLE 549         NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED        458

TABLE 550         NOVONESIS GROUP: PRODUCT LAUNCHES            459

TABLE 551         NOVONESIS GROUP: DEALS         459

TABLE 552         NOVONESIS GROUP: EXPANSIONS            460

TABLE 553         INDIGO AG, INC.: COMPANY OVERVIEW      462

TABLE 554         INDIGO AG, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED        463

TABLE 555         INDIGO AG, INC.: PRODUCT LAUNCHES      464

TABLE 556         INDIGO AG, INC.: DEALS   464

TABLE 557         INDIGO AG, INC.: EXPANSIONS      465

TABLE 558         PIVOT BIO: COMPANY OVERVIEW  466

TABLE 559         PIVOT BIO.: PRODUCTS/SOLUTIONS/SERVICES OFFERED           467

TABLE 560         PIVOT BIO: OTHER DEVELOPMENTS          467

TABLE 561         PIVOT BIO.: EXPANSIONS 468

TABLE 562         BIOATLANTIS LTD.: COMPANY OVERVIEW  470

TABLE 563         BIOATLANTIS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED        471

TABLE 564         BIOATLANTIS LTD.: PRODUCT LAUNCHES  471

TABLE 565         BIOATLANTIS LTD.: DEALS           472

TABLE 566         CERTIS USA L.L.C.: COMPANY OVERVIEW   474

TABLE 567         CERTIS USA L.L.C.: PRODUCTS/SOLUTIONS/SERVICES OFFERED        475

TABLE 568         CERTIS USA L.L.C.: PRODUCT LAUNCHES  477

TABLE 569         CERTIS USA L.L.C.: DEALS            477

TABLE 570         ZYMOLENT BIOSCIENCES PVT. LTD.: COMPANY OVERVIEW         478

TABLE 571         ZYMOLENT BIOSCIENCES PVT. LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED        479

TABLE 572         ZYMOLENT BIOSCIENCES PVT. LTD.: OTHER DEVELOPMENTS 479

TABLE 573         AGRICEN: COMPANY OVERVIEW    480

TABLE 574         AGRICEN: PRODUCTS/SOLUTIONS/SERVICES OFFERED           481

TABLE 575         AGRICEN: DEALS 481

TABLE 576         VARSHA BIOSCIENCE AND TECHNOLOGY INDIA PVT LTD.: COMPANY OVERVIEW          483

TABLE 577         VARSHA BIOSCIENCE AND TECHNOLOGY INDIA PVT LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 484

TABLE 578         GROUNDWORK BIOAG: COMPANY OVERVIEW            487

TABLE 579         GROUNDWORK BIOAG: PRODUCTS/SOLUTIONS/SERVICES OFFERED        488

TABLE 580         GROUNDWORK BIOAG: PRODUCT LAUNCHES            489

TABLE 581         GROUNDWORK BIOAG: DEALS      489

TABLE 582         ADJACENT MARKETS TO AGRICULTURE BIOTECHNOLOGY MARKET          491

TABLE 583         PLANT BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2020–2024 (USD MILLION)    492

TABLE 584         PLANT BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION)    493

TABLE 585         AGRICULTURAL MICROBIALS MARKET, BY APPLICATION,

2019–2024 (USD MILLION) 494

TABLE 586         AGRICULTURAL MICROBIALS MARKET, BY APPLICATION,

2025–2030 (USD MILLION) 494

LIST OF FIGURES

FIGURE 1           MARKET SEGMENTATION AND REGIONS COVERED            47

FIGURE 2           AGRICULTURE BIOTECHNOLOGY MARKET: RESEARCH DESIGN         52

FIGURE 3           BRIEF OF BOTTOM-UP APPROACH          57

FIGURE 4           AGRICULTURAL BIOTECHNOLOGY MARKET: BOTTOM-UP APPROACH 58

FIGURE 5           AGRICULTURAL BIOTECHNOLOGY MARKET: TOP-DOWN APPROACH          59

FIGURE 6           BRIEF OF TOP-DOWN APPROACH 60

FIGURE 7           DATA TRIANGULATION    61

FIGURE 8           AGRICULTURE BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025 VS. 2030 (USD MILLION)        67

FIGURE 9           PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)   67

FIGURE 10         ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025 VS. 2030 (USD MILLION)        68

FIGURE 11         MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025 VS. 2030 (USD MILLION)        69

FIGURE 12         AGRICULTURE BIOTECHNOLOGY MARKET SHARE, BY REGION        70

FIGURE 13         ADVANCEMENTS IN GENE EDITING, DIGITAL AGRICULTURE, AND MICROBIAL TECHNOLOGIES TO ACCELERATE GLOBAL AGRICULTURE BIOTECHNOLOGY ADOPTION AND DRIVE SUBSTANTIAL MARKET EXPANSION          71

FIGURE 14         STRONG BIOTECHNOLOGY ADOPTION ACROSS MAJOR AGRICULTURAL ECONOMIES TO PROPEL REGIONAL GROWTH, WITH ASIA PACIFIC AND EUROPE EMERGING AS SIGNIFICANT FUTURE EXPANSION CENTERS     72

FIGURE 15         EUROPE’S BIOTECHNOLOGY DEMAND TO INCREASE DUE TO SUSTAINABILITY MANDATES, CROP PROTECTION INNOVATIONS, AND GROWING RELIANCE ON SOIL ENHANCEMENT AND STRESS-TOLERANCE SOLUTIONS     73

FIGURE 16         DIVERSE REGIONAL INVESTMENTS IN PLANT, ANIMAL, AND MICROBIAL TECHNOLOGIES TO SHAPE GLOBAL MARKET DISTRIBUTION AND STRENGTHEN AGRICULTURAL BIOTECHNOLOGY CAPABILITIES WORLDWIDE         74

FIGURE 17         RAPID PROGRESS IN FERMENTATION, METAGENOMICS, MOLECULAR SELECTION, AND SYNTHETIC BIOLOGY TO SUPPORT HIGH-GROWTH MICROBIAL BIOTECHNOLOGY APPLICATIONS   75

FIGURE 18         INCREASING FOCUS ON PRODUCTIVITY, DISEASE RESISTANCE, ADVANCED THERAPEUTICS, AND WELFARE SOLUTIONS TO BROADEN ANIMAL BIOTECHNOLOGY ADOPTION           75

FIGURE 19         PLANT BIOTECHNOLOGY GROWTH DRIVEN BY INNOVATIONS ENHANCING YIELD, PROTECTION, RESILIENCE, AND NUTRITIONAL QUALITY   76

FIGURE 20         AGRICULTURE BIOTECHNOLOGY MARKET DYNAMICS         78

FIGURE 21         ADOPTION OF GEN AI IN AGRICULTURE BIOTECHNOLOGY           84

FIGURE 22         PORTER’S FIVE FORCES ANALYSIS: AGRICULTURE BIOTECHNOLOGY MARKET          88

FIGURE 23         GLOBAL POPULATION GROWTH, 1950–2050 (BILLION)           90

FIGURE 24         GDP GROWTH, 2016–2023 (USD TRILLION)  91

FIGURE 25         COMPREHENSIVE SUPPLY CHAIN STRUCTURE OF AGRICULTURE BIOTECHNOLOGY MARKET DRIVEN BY CLIMATE-SMART TECHNOLOGIES AND POLICY ALIGNMENT   92

FIGURE 26         AGRICULTURE BIOTECHNOLOGY MARKET: VALUE CHAIN   93

FIGURE 27         AGRICULTURE BIOTECHNOLOGY MARKET: ECOSYSTEM ANALYSIS   93

FIGURE 28         EXPORT VALUE OF AGRICULTURE BIOTECHNOLOGY UNDER HS CODE 382100 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)        100

FIGURE 29         IMPORT VALUE OF AGRICULTURE BIOTECHNOLOGY UNDER HS CODE 382100 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)       101

FIGURE 30         TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS          105

FIGURE 31         INVESTMENT AND FUNDING SCENARIO, 2020–2025 (USD MILLION)    105

FIGURE 32         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AGRICULTURE BIOTECHNOLOGY TYPE        112

FIGURE 33         KEY BUYING CRITERIA FOR AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE        113

FIGURE 34         COMMERCIAL DEPLOYMENT & FUTURE ECOSYSTEM (2032–2035)        118

FIGURE 35         NUMBER OF PATENTS GRANTED FOR AGRICULTURE BIOTECHNOLOGY MARKET, 2014–2024         119

FIGURE 36         REGIONAL ANALYSIS OF PATENTS GRANTED FOR AGRICULTURE BIOTECHNOLOGY MARKET, 2014–2024         120

FIGURE 37         AGRICULTURE BIOTECHNOLOGY MARKET, BY TYPE OF ORGANISM,

2025 VS. 2030 (USD MILLION)        138

FIGURE 38         PLANT BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)   145

FIGURE 39         ANIMAL BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)   151

FIGURE 40         MICROBIAL BIOTECHNOLOGY MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)        154

FIGURE 41         PLANT BIOTECHNOLOGY MARKET, BY APPLICATION,

2025 VS. 2030 (USD MILLION)      160

FIGURE 42         ANIMAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025 VS. 2030 (USD MILLION)        163

FIGURE 43         MICROBIAL BIOTECHNOLOGY MARKET, BY APPLICATION,

2025 VS. 2030 (USD MILLION)        166

FIGURE 44         PLANT BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025 VS. 2030 (USD MILLION)        170

FIGURE 45         ANIMAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025 VS. 2030 (USD MILLION)        173

FIGURE 46         MICROBIAL BIOTECHNOLOGY MARKET, BY TECHNOLOGY,

2025 VS. 2030 (USD MILLION)        176

FIGURE 47         INDIA TO BE FASTEST-GROWING COUNTRY IN AGRICULTURE

BIOTECHNOLOGY MARKET, 2025–2030       181

FIGURE 48         NORTH AMERICA: AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT       185

FIGURE 49         ASIA PACIFIC: AGRICULTURE BIOTECHNOLOGY MARKET SNAPSHOT       245

FIGURE 50         AGRICULTURE PLANT BIOTECHNOLOGY: REVENUE ANALYSIS FOR

FIVE KEY PLAYERS, 2022–2024 (USD BILLION)        329

FIGURE 51         AGRICULTURE ANIMAL BIOTECHNOLOGY: REVENUE ANALYSIS FOR

FIVE KEY PLAYERS, 2022–2024 (USD BILLION)        329

FIGURE 52         AGRICULTURE MICROBIAL BIOTECHNOLOGY: REVENUE ANALYSIS

FOR KEY PLAYERS, 2022–2024 (USD BILLION)         330

FIGURE 53         SHARE OF LEADING COMPANIES IN PLANT BIOTECHNOLOGY MARKET, 2024  332

FIGURE 54         SHARE OF LEADING COMPANIES IN ANIMAL BIOTECHNOLOGY MARKET, 2024  333

FIGURE 55         SHARE OF LEADING COMPANIES IN MICROBIAL BIOTECHNOLOGY MARKET, 2024  334

FIGURE 56         BRAND/PRODUCT COMPARISON, BY APPLICATION            335

FIGURE 57         COMPANY VALUATION OF KEY AGRICULTURE BIOTECHNOLOGY VENDORS        337

FIGURE 58         EV/EBITDA OF KEY COMPANIES   337

FIGURE 59         PLANT BIOTECHNOLOGY MARKET: COMPANY EVALUATION

MATRIX (KEY PLAYERS), 2024       339

FIGURE 60         PLANT BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT       340

FIGURE 61         ANIMAL BIOTECHNOLOGY MARKET: COMPANY EVALUATION

MATRIX (KEY PLAYERS), 2024       343

FIGURE 62         ANIMAL BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT       344

FIGURE 63         MICROBIAL BIOTECHNOLOGY MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       347

FIGURE 64         MICROBIAL BIOTECHNOLOGY MARKET: COMPANY FOOTPRINT       348

FIGURE 65         BASF SE: COMPANY SNAPSHOT   357

FIGURE 66         BAYER AG: COMPANY SNAPSHOT 363

FIGURE 67         CORTEVA AGRISCIENCE: COMPANY SNAPSHOT            370

FIGURE 68         SYNGENTA: COMPANY SNAPSHOT            378

FIGURE 69         KWS SAAT SE & CO. KGAA: COMPANY SNAPSHOT            389

FIGURE 70         UPL: COMPANY SNAPSHOT         395

FIGURE 71         FMC CORPORATION: COMPANY SNAPSHOT            403

FIGURE 72         SUMITOMO CHEMICAL CO., LTD.: COMPANY SNAPSHOT        409

FIGURE 73         NUFARM: COMPANY SNAPSHOT   414

FIGURE 74         ZOETIS INC.: COMPANY SNAPSHOT          421

FIGURE 75         ELANCO OR ITS AFFILIATES: COMPANY SNAPSHOT            425

FIGURE 76         MERCK & CO., INC.: COMPANY SNAPSHOT 429

FIGURE 77         VIRBAC: COMPANY SNAPSHOT    436

FIGURE 78         HESTER BIOSCIENCES LIMITED: COMPANY SNAPSHOT        440

FIGURE 79         GENUS PLC: COMPANY SNAPSHOT           443

FIGURE 80         BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT     450

FIGURE 81         NOVONESIS GROUP: COMPANY SNAPSHOT            458

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧